| Literature DB >> 31563231 |
Simy K Parikh1, Stephen D Silberstein2.
Abstract
Episodic migraine is a debilitating condition. Preventive therapy is used to reduce frequency, duration, or severity of attacks. This review discusses principles of preventive treatment with a focus on preventive treatment options for people with episodic migraine. Specifically discussed is evidence and use of new migraine-specific treatment options for episodic migraine, such as calcitonin gene-related peptide monoclonal antibodies, a noninvasive transcutaneous electrical nerve stimulation device, and a single-pulse transcranial magnetic stimulator device. Also discussed are evidence-based updates from the 2012 American Academy of Neurology and the American Headache Society guidelines regarding major medication classes recommended for preventive episodic migraine treatment.Entities:
Keywords: CGRP monoclonal antibodies; Diagnosis; Episodic migraine; Headache; Prevention; Single-pulse transcranial magnetic stimulator; Transcutaneous electrical nerve stimulation; Treatment
Mesh：
Substances：
Year: 2019 PMID： 31563231 DOI： 10.1016/j.ncl.2019.07.004
Source DB: PubMed Journal: Neurol Clin ISSN： 0733-8619 Impact factor: 3.806